Pankit Jaysukh Vachhani MD

PubMed

• Real-World Evidence of Treatment-Free Remission Strategies and Outcomes in Chronic Myeloid Leukemia.
  Garrett Bourne, Kendall Diebold, Greg Bascug, Joshua Knapp, Manuel Espinoza-Gutarra
  Cancers. 2025-06-26
• Outcomes With Venetoclax 50 mg, Hypomethylating Agents, and Voriconazole or Posaconazole in Acute Myeloid Leukemia.
  Kendall Diebold, Devan Parker, Sarah Worth, Manuel Espinoza-Gutarra, Pankit Vachhani
  Ejhaem. 2025-06-01
• Momelotinib - a tale of trials, tribulations, transfusion independence, and triumph.
  Ruchi J Desai, Pankit Vachhani, Prithviraj Bose
  Expert Opinion on Drug Discovery. 2025-06-01

Journal Articles

• Intensive Chemotherapy vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center Experience  
  Pankit Vachhani, Evelena P Ontiveros, Leukemia Research
• Intensive Chemotherapy vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center Experience  
  Pankit Vachhani, Evelena P Ontiveros, Leukemia Research

Abstracts/Posters

• Genetic Alterations at Diagnosis Predict Outcome of AML Patients Age 60 or Older Undergoing Allogeneic Transplantation in First RemissionClinically Relevant Abstract
  Pankit Vachhani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Preliminary Results from a Phase 1 First-in-Human Study of AMG 673, a Novel Half-Life Extended (HLE) Anti-CD33/CD3 BiTE¬ (Bispecific T-Cell Engager) in Patients with R...
  Pankit Vachhani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Quantification of Humoral Immune Response to Influenza Vaccination in MDS 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019